









Markets
/
Stocks
/
nasdaq-ecor
/

electroCore, Inc.

ECOR

5.650USD

-0.370-6.15%

Close 03/30, 16:00（ET）Quotes delayed by 15 min

10.71MMarket Cap

LossP/E TTM



electroCore, Inc.

5.650

-0.370-6.15%

Overview Financials Analysis Company

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

Overview

Financials

Analysis

Company

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

TradingKey Stock Score of electroCore, Inc.

Currency: USD Updated: 2026-03-27

Key Insights

electroCore, Inc.'s fundamentals are relatively healthy, with an industry-leading ESG disclosure.and its growth potential is high.Its valuation is considered fairly valued, ranking 91 out of 208 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 19.80.In the medium term, the stock price is expected to trend up.Despite a very weak market performance over the past month, the company shows strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

electroCore, Inc.'s Score

Industry at a Glance

Industry Ranking

91 / 208

Overall Ranking

221 / 4542

Industry

Healthcare Equipment & Supplies

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score

Previous score

Media Coverage

Last 24 hours

Coverage Level

Very Low

Very High

Neutral

electroCore, Inc. Highlights

StrengthsRisks

electroCore, Inc. is a commercial stage bioelectronic medicine and wellness company focused on improving health through its non-invasive vagus nerve stimulation (nVNS) technology platform and related product offerings. The Company’s portfolio also includes Quell, a wearable, app and cloud-enabled neuromodulation platform that is indicated for the treatment of fibromyalgia symptoms and lower-extremity chronic pain. Its product categories include handheld, personal use medical devices for the management and treatment of certain medical conditions such as primary headaches, and handheld, personal use consumer products. Its products include gammaCore, Quell Fibromyalgia, Truvaga and TAC-STIM. Its gammaCore Sapphire is a prescription medical device that is used for a variety of primary headache conditions. Truvaga is a personal-use consumer electronics general wellness product that does not require a prescription and is available direct-to-consumer from electroCore at www.truvaga.com.

High Growth

The company's revenue has grown steadily over the past 3 years, averaging 99.83% year-on-year.

Growing

The company is in a growing phase, with the latest annual income totaling USD 32.03M.

Fairly Valued

The company’s latest PE is -3.56, at a medium 3-year percentile range.

Held by The Vanguard

Star Investor The Vanguard holds 242.94K shares of this stock.

Higher Market Activity

The company has more investor interest, with a 20-day turnover ratio of 0.69.

Analyst Rating

Based on 5 analysts

Buy

Current Rating

19.800

Target Price

+228.90%

Upside Space

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Financial Health

Currency: USD Updated: 2026-03-27

The current financial score of electroCore, Inc. is 7.03, ranking 93 out of 208 in the Healthcare Equipment & Supplies industry. Its financial status is stable, and its operating efficiency is average. Its latest quarterly revenue reached 9.24M, representing a year-over-year increase of 31.18%, while its net profit experienced a year-over-year increase of 5.98%.

Score

Industry at a Glance

Previous score

7.03

Change



Financials

6.21

Key Metrics

Cash and cash equivalents

Total assets

Total liabilities

Free cash flow

Relevant data have not been disclosed by the company yet.



Quality of Earnings

7.03

Key Metrics

Total revenue

Operating profit

Total assets

SG&A

Relevant data have not been disclosed by the company yet.



Operational Efficiency

6.89

Key Metrics

Cash flow from operating activities

Income after tax

Relevant data have not been disclosed by the company yet.



Growth Potential

7.80

Key Metrics

Cash flow from operating activities

Total revenue

Relevant data have not been disclosed by the company yet.



Shareholder Returns

7.20

Key Metrics

Free cash flow

Relevant data have not been disclosed by the company yet.

electroCore, Inc.'s Company Valuation

Currency: USD Updated: 2026-03-27

The current valuation score of electroCore, Inc. is 7.27, ranking 99 out of 208 in the Healthcare Equipment & Supplies industry. Its current P/E ratio is -3.56, which is -81.24% below the recent high of -0.67 and -242.61% above the recent low of -12.19.

Score

Industry at a Glance

Previous score

7.27

Change

Valuation Dimensions

P/E

P/B

P/S

P/CF

Industry Ranking 91/208

Relevant data have not been disclosed by the company yet.

Earnings Forecast

Currency: USD Updated: 2026-03-27

The current earnings forecast score of electroCore, Inc. is 8.40, ranking 34 out of 208 in the Healthcare Equipment & Supplies industry. The average price target is 23.40, with a high of 25.00 and a low of 12.00.

Score

Industry at a Glance

Previous score

8.40

Change

Support & Resistance

Relevant data have not been disclosed by the company yet.

Analyst Rating

Based on 5 analysts

Buy

Current Rating

19.800

Target Price

+237.88%

Upside Space

Strong Buy

Buy

Hold

Sell

Strong Sell

Peer Comparison

115

Total

Median

Average

Company name

Ratings

Analysts

electroCore, Inc.

ECOR

Medtronic PLC

MDT

Stryker Corp

SYK

Dexcom Inc

DXCM

Zimmer Biomet Holdings Inc

ZBH

Abbott Laboratories

ABT

...

Financial Forecasting

EPS

Revenue

Net Profit

EBIT

Relevant data have not been disclosed by the company yet.

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated: 2026-03-27

The current price momentum score of electroCore, Inc. is 6.77, ranking 65 out of 208 in the Healthcare Equipment & Supplies industry. Currently, the stock price is trading between the resistance level at 7.53 and the support level at 4.88, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score

6.90

Change

-0.13

Support & Resistance

Relevant data have not been disclosed by the company yet.

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators

Sell(5)

Neutral(1)

Buy(0)

Indicators

Value

Direction

MACD(12,26,9)

-0.197

Sell

RSI(14)

41.671

Neutral

STOCH(KDJ)(9,3,3)

28.013

Sell

ATR(14)

0.651

High Vlolatility

CCI(14)

-122.397

Sell

Williams %R

82.649

Oversold

TRIX(12,20)

-0.251

Sell

StochRSI(14)

0.000

Sell

Moving Average

Sell(6)

Neutral(0)

Buy(0)

Indicators

Value

Direction

MA5

6.174

Sell

MA10

6.367

Sell

MA20

6.670

Sell

MA50

6.605

Sell

MA100

5.849

Sell

MA200

5.708

Sell

Institutional Confidence

Currency: USD Updated: 2026-03-27

The current institutional shareholding score of electroCore, Inc. is 3.00, ranking 135 out of 208 in the Healthcare Equipment & Supplies industry. The latest institutional shareholding proportion is 16.70%, representing a quarter-over-quarter decrease of 5.16%. The largest institutional shareholder is The Vanguard, holding a total of 242.94K shares, representing 3.01% of shares outstanding, with 6.95% decrease in holdings.

Score

Industry at a Glance

Previous score

3.00

Change

Institutional Shareholding

Relevant data have not been disclosed by the company yet.

Shareholder Activity

Name

Shares Held

Chg %

Zhang (Tianyi)

734.64K

Theofilos (Charles Steve)

444.53K

Hilve Holdings Ltd

432.00K

Errico (Thomas J.)

306.38K

+9.51%

The Vanguard Group, Inc.

Star Investors

233.47K

+0.49%

Goldberger (Daniel S)

185.90K

+0.54%

Happy Holstein Management, LLC

153.17K

MAZ Partners, L.P.

115.52K

-57.52%

Patton (Thomas M)

102.78K

+22.69%

Goldstein (Julie Ann)

101.39K

+23.08%

Risk Assessment

Currency: USD Updated: 2026-03-27

The U.S. Dollar Index is currently in a neutral state, which has a neutral effect on the Healthcare Equipment & Supplies domestic-focused industry. The Dollar Index (DXY) measures the value of the U.S. dollar against a basket of major currencies, including the euro, yen, pound sterling, Canadian dollar, Swedish krona, and Swiss franc. The current risk assessment score of electroCore, Inc. is 2.95, ranking 138 out of 208 in the Healthcare Equipment & Supplies industry. The company's beta value is 0.59. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets. with an industry-leading ESG disclosure.